Recent Quarter Total Invested
$47.86 M
Recent Quarter Institutional Ownership Percentage
60.1%
Total Invested of Last Quarter
$42.74 M
Ownership Percentage of Last Quarter
72.12%
Ikena Oncology, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 08/09/2024 | 5.02 M | $8.28 M | 0.00% | 10.40% |
BVF INC/IL | 08/14/2024 | 4.77 M | $7.87 M | 0.00% | 9.88% |
BLUE OWL CAPITAL HOLDINGS LP | 08/15/2024 | 4.09 M | $6.75 M | 5.14% | 8.48% |
ORBIMED ADVISORS LLC | 08/14/2024 | 3.54 M | $5.84 M | 0.00% | 7.33% |
OMEGA FUND MANAGEMENT, LLC | 08/14/2024 | 2.25 M | $3.71 M | 0.00% | 4.66% |
VANGUARD GROUP INC | 08/13/2024 | 1.36 M | $2.25 M | -10.95% | 2.83% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2024 | 987,900 | $1.63 M | 243.14% | 2.05% |
BML CAPITAL MANAGEMENT, LLC | 08/07/2024 | 585,114 | $965,438 | 100.00% | 1.21% |
NEA MANAGEMENT COMPANY, LLC | 08/14/2024 | 570,050 | $940,583 | 0.00% | 1.18% |
RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 476,400 | $786,060 | -38.66% | 0.99% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2024 | 424,377 | $700,222 | -17.35% | 0.88% |
ACUITAS INVESTMENTS, LLC | 08/05/2024 | 399,879 | $659,800 | 0.54% | 0.83% |
SOFINNOVA INVESTMENTS, INC. | 08/09/2024 | 382,616 | $631,316 | 0.00% | 0.79% |
BLACKROCK INC. | 08/13/2024 | 354,842 | $585,489 | -80.60% | 0.74% |
MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 354,710 | $585,272 | 100.00% | 0.74% |
ACADIAN ASSET MANAGEMENT LLC | 08/06/2024 | 325,713 | $536,000 | 15.18% | 0.67% |
GOLDMAN SACHS GROUP INC | 08/13/2024 | 273,834 | $451,827 | 277.20% | 0.57% |
GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 256,707 | $423,669 | -57.02% | 0.53% |
CITADEL ADVISORS LLC | 08/14/2024 | 244,690 | $403,739 | 53.88% | 0.51% |
TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 236,878 | $390,849 | -2.50% | 0.49% |
NORTHERN TRUST CORP | 08/14/2024 | 216,851 | $357,804 | -7.44% | 0.45% |
BARCLAYS PLC | 08/14/2024 | 196,044 | $324,000 | -0.39% | 0.41% |
TWO SIGMA ADVISERS, LP | 08/14/2024 | 173,200 | $285,780 | 116.77% | 0.36% |
VERITION FUND MANAGEMENT LLC | 08/14/2024 | 135,297 | $223,240 | -88.08% | 0.28% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 83,218 | $137,310 | 100.00% | 0.17% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2024 | 82,300 | $135,795 | 0.00% | 0.17% |
DEUTERIUM CAPITAL MANAGEMENT, LLC | 07/30/2024 | 80,578 | $132,954 | 100.00% | 0.17% |
STATE STREET CORP | 08/14/2024 | 80,353 | $132,582 | -83.35% | 0.17% |
CENTIVA CAPITAL, LP | 08/14/2024 | 73,431 | $121,161 | 100.00% | 0.15% |
MARQUETTE ASSET MANAGEMENT, LLC | 08/14/2024 | 72,890 | $120,269 | 0.00% | 0.15% |
JBF CAPITAL, INC. | 08/08/2024 | 72,647 | $119,867 | 100.00% | 0.15% |
ALPINE GLOBAL MANAGEMENT, LLC | 08/14/2024 | 64,641 | $106,658 | 100.00% | 0.13% |
Y-INTERCEPT (HONG KONG) LTD | 08/14/2024 | 60,628 | $100,036 | 100.00% | 0.13% |
JANE STREET GROUP, LLC | 08/15/2024 | 55,840 | $92,136 | 100.00% | 0.12% |
ADAR1 CAPITAL MANAGEMENT, LLC | 08/13/2024 | 46,685 | $77,030 | 33.39% | 0.10% |
POINT72 ASIA (SINGAPORE) PTE. LTD. | 09/16/2024 | 45,520 | $75,108 | 100.00% | 0.09% |
MARSHALL WACE, LLP | 08/14/2024 | 44,933 | $74,140 | -49.34% | 0.09% |
UBS GROUP AG | 08/14/2024 | 41,818 | $69,000 | 27.69% | 0.09% |
MORGAN STANLEY | 10/17/2024 | 40,874 | $67,441 | -17.33% | 0.08% |
DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 38,621 | $64,009 | 0.00% | 0.08% |
QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 34,941 | $57,652 | 100.00% | 0.07% |
PALOMA PARTNERS MANAGEMENT CO | 08/14/2024 | 30,240 | $49,896 | 100.00% | 0.06% |
PRUDENTIAL FINANCIAL INC | 08/13/2024 | 29,800 | $49,170 | 76.12% | 0.06% |
VIRTU FINANCIAL LLC | 08/09/2024 | 28,053 | $46,000 | 100.00% | 0.06% |
SQUAREPOINT OPS LLC | 08/14/2024 | 27,666 | $45,649 | 100.00% | 0.06% |
HRT FINANCIAL LP | 08/12/2024 | 26,893 | $44,000 | 100.00% | 0.06% |
CORSAIR CAPITAL MANAGEMENT, L.P. | 08/13/2024 | 24,830 | $40,970 | 100.00% | 0.05% |
AQR CAPITAL MANAGEMENT LLC | 08/14/2024 | 21,861 | $36,071 | 100.00% | 0.05% |
TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 20,132 | $33,218 | 125.49% | 0.04% |
BERKSHIRE ASSET MANAGEMENT LLC/PA | 08/13/2024 | 20,000 | $33,000 | 100.00% | 0.04% |
Ikena Oncology, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of IKNA shares?
During the previous two years, 75 institutional investors and hedge funds held shares of Ikena Oncology, Inc.. The most heavily invested institutionals were:
Atlas Venture Life Science Advisors, LLC: 5.02 M
BVF INC/IL: 4.77 M
Blue Owl Capital Holdings LP: 4.09 M
ORBIMED ADVISORS LLC: 3.54 M
Omega Fund Management, LLC: 2.25 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 987,900
-
What percentage of Ikena Oncology, Inc. stock is owned by institutional investors?
60.10% of Ikena Oncology, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at IKNA ?
Institutional investors have bought a total of 29.43 M shares in the last 24 months. This purchase volume represents approximately $50.33 M in transactions.